Literature DB >> 9811709

Cytoplasmic domain of Sendai virus HN protein contains a specific sequence required for its incorporation into virions.

T Takimoto1, T Bousse, E C Coronel, R A Scroggs, A Portner.   

Abstract

In the assembly of paramyxoviruses, interactions between viral proteins are presumed to be specific. The focus of this study is to elucidate the protein-protein interactions during the final stage of viral assembly that result in the incorporation of the viral envelope proteins into virions. To this end, we examined the specificity of HN incorporation into progeny virions by transiently transfecting HN cDNA genes into Sendai virus (SV)-infected cells. SV HN expressed from cDNA was efficiently incorporated into progeny Sendai virions, whereas Newcastle disease virus (NDV) HN was not. This observation supports the theory of a selective mechanism for HN incorporation. To identify the region on HN responsible for the selective incorporation, we constructed chimeric SV and NDV HN cDNAs and evaluated the incorporation of expressed proteins into progeny virions. Chimera HN that contained the SV cytoplasmic domain fused to the transmembrane and external domains of the NDV HN was incorporated to SV particles, indicating that amino acids in the cytoplasmic domain are responsible for the observed specificity. Additional experiments using the chimeric HNs showed that 14 N-terminal amino acids are sufficient for the specificity. Further analysis identified five consecutive amino acids (residues 10 to 14) that were required for the specific incorporation of HN into SV. These residues are conserved among all strains of SV as well as those of its counterpart, human parainfluenza virus type 1. These results suggest that this region near the N terminus of HN interacts with another viral protein(s) to lead to the specific incorporation of HN into progeny virions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9811709      PMCID: PMC110485     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses.

Authors:  E Kretzschmar; L Buonocore; M J Schnell; J K Rose
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  A temperature-sensitive mutant of Sendai virus with an altered hemagglutinin-neuraminidase polypeptide: consequences for virus assembly and cytopathology.

Authors:  A Portner; R A Scroggs; P S Marx; D W Kingsbury
Journal:  Virology       Date:  1975-09       Impact factor: 3.616

3.  The role of haemagglutinin-neuraminidase glycoprotein cell surface expression in the survival of Sendai virus-infected BHK-21 cells.

Authors:  C Tuffereau; A Portner; L Roux
Journal:  J Gen Virol       Date:  1985-11       Impact factor: 3.891

4.  Isolation and characterization of Sendai virus temperature-sensitive mutants.

Authors:  A Portner; P A Marx; D W Kingsbury
Journal:  J Virol       Date:  1974-02       Impact factor: 5.103

5.  Structural and functional analysis of Sendai virus nucleocapsid protein NP with monoclonal antibodies.

Authors:  K L Deshpande; A Portner
Journal:  Virology       Date:  1984-11       Impact factor: 3.616

6.  Protein-protein interactions within paramyxoviruses identified by native disulfide bonding or reversible chemical cross-linking.

Authors:  M A Markwell; C F Fox
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

7.  Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system.

Authors:  R B DuBridge; P Tang; H C Hsia; P M Leong; J H Miller; M P Calos
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

8.  An alternative route of infection for viruses: entry by means of the asialoglycoprotein receptor of a Sendai virus mutant lacking its attachment protein.

Authors:  M A Markwell; A Portner; A L Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

9.  The predicted primary structure of the measles virus hemagglutinin.

Authors:  G Alkhatib; D J Briedis
Journal:  Virology       Date:  1986-04-30       Impact factor: 3.616

10.  The nucleotide sequence of the mRNA encoding the fusion protein of measles virus (Edmonston strain): a comparison of fusion proteins from several different paramyxoviruses.

Authors:  C Richardson; D Hull; P Greer; K Hasel; A Berkovich; G Englund; W Bellini; B Rima; R Lazzarini
Journal:  Virology       Date:  1986-12       Impact factor: 3.616

View more
  33 in total

1.  Role of the hemagglutinin-neuraminidase protein in the mechanism of paramyxovirus-cell membrane fusion.

Authors:  Toru Takimoto; Garry L Taylor; Helen C Connaris; Susan J Crennell; Allen Portner
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 2.  Baculovirus as a vaccine vector.

Authors:  Hsin-Yu Lu; Yi-Hsuan Chen; Hung-Jen Liu
Journal:  Bioengineered       Date:  2012-06-18       Impact factor: 3.269

3.  Role of the transmembrane domain of marburg virus surface protein GP in assembly of the viral envelope.

Authors:  Eva Mittler; Larissa Kolesnikova; Thomas Strecker; Wolfgang Garten; Stephan Becker
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

4.  Effect of hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 on growth and pathogenicity of Sendai/human parainfluenza type 3 chimera virus in mice.

Authors:  Makiko Watanabe; Vasiliy P Mishin; Scott A Brown; Charles J Russell; Kelli Boyd; Y Sudhakara Babu; Garry Taylor; Xiaoping Xiong; Xiaowei Yan; Allen Portner; Irina V Alymova
Journal:  Antimicrob Agents Chemother       Date:  2009-06-29       Impact factor: 5.191

5.  Nucleocapsid incorporation into parainfluenza virus is regulated by specific interaction with matrix protein.

Authors:  E C Coronel; T Takimoto; K G Murti; N Varich; A Portner
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

6.  AIP1/Alix is a binding partner of Sendai virus C protein and facilitates virus budding.

Authors:  Takemasa Sakaguchi; Atsushi Kato; Fumihiro Sugahara; Yukie Shimazu; Makoto Inoue; Katsuhiro Kiyotani; Yoshiyuki Nagai; Tetsuya Yoshida
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

7.  Role of matrix and fusion proteins in budding of Sendai virus.

Authors:  T Takimoto; K G Murti; T Bousse; R A Scroggs; A Portner
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

8.  N-linked glycan at residue 523 of human parainfluenza virus type 3 hemagglutinin-neuraminidase masks a second receptor-binding site.

Authors:  Vasiliy P Mishin; Makiko Watanabe; Garry Taylor; John Devincenzo; Michael Bose; Allen Portner; Irina V Alymova
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

9.  Recombinant Sendai virus expressing the G glycoprotein of respiratory syncytial virus (RSV) elicits immune protection against RSV.

Authors:  Toru Takimoto; Julia L Hurwitz; Chris Coleclough; Cecilia Prouser; Sateesh Krishnamurthy; Xiaoyan Zhan; Kelli Boyd; Ruth A Scroggs; Brita Brown; Yoshiyuki Nagai; Allen Portner; Karen S Slobod
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

10.  The baculovirus GP64 protein mediates highly stable infectivity of a human respiratory syncytial virus lacking its homologous transmembrane glycoproteins.

Authors:  A G P Oomens; Gail W Wertz
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.